Synairgen Historical Cash Flow
| SNG Stock | 4.40 0.32 6.78% |
Analysis of Synairgen Plc cash flow over time is an excellent tool to project Synairgen plc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 1.1 K or End Period Cash Flow of 12.7 M as it is a great indicator of Synairgen Plc ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Synairgen plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Synairgen plc is a good buy for the upcoming year.
Synairgen |
About Synairgen Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Synairgen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Synairgen's non-liquid assets can be easily converted into cash.
Synairgen Plc Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Synairgen Plc's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Synairgen plc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synairgen plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, Synairgen Plc's Other Non Cash Items is projected to decrease significantly based on the last few years of reporting. The current year's End Period Cash Flow is expected to grow to about 12.7 M, whereas Free Cash Flow is forecasted to decline to (8.7 M).
| 2023 | 2024 (projected) | Sale Purchase Of Stock | 900.0 | 855.0 | Stock Based Compensation | 790K | 829.5K |
Synairgen Plc cash flow statement Correlations
Click cells to compare fundamentals
Synairgen Plc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Synairgen Plc cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (2.8M) | 72.5M | (41.1M) | (17.9M) | (5.4M) | (5.1M) | |
| Free Cash Flow | (2.9M) | (23.9M) | (41.0M) | (14.2M) | (8.3M) | (8.7M) | |
| Change In Working Capital | 809K | (7.5M) | 12.2M | (4.1M) | (1.2M) | (1.2M) | |
| Other Cashflows From Financing Activities | 40K | (3.4M) | (126K) | (3.8M) | 2.8M | 3.0M | |
| Depreciation | 163K | 260K | 195K | 102K | 84K | 77.6K | |
| Other Non Cash Items | (440K) | 5.3M | (16.6M) | 7.4M | 531K | 557.6K | |
| Capital Expenditures | 10K | 76K | 33K | 6K | 13K | 12.4K | |
| Total Cash From Operating Activities | (2.9M) | (23.8M) | (41.0M) | (14.1M) | (8.2M) | (8.6M) | |
| Total Cash From Financing Activities | 2.7M | 2.7K | 96.4M | (112K) | 1.2K | 1.1K | |
| Begin Period Cash Flow | 4.8K | 5.3M | 2.5M | 33.8M | 15.9M | 12.6M | |
| Stock Based Compensation | 111K | 207K | 508K | 919K | 790K | 829.5K | |
| Investments | 50K | (45K) | (21K) | (3.6M) | 2.8M | 3.0M | |
| Total Cashflows From Investing Activities | 66K | (45K) | (21K) | (3.6M) | (3.3M) | (3.1M) | |
| Change To Account Receivables | 81K | (9.2M) | 7.8M | 289K | 473K | 496.7K | |
| Other Cashflows From Investing Activities | 27K | 26K | 31K | 140K | 161K | 169.1K | |
| Change To Netincome | 17K | (2.7M) | (4.8M) | 7.4M | 8.5M | 8.9M | |
| Change To Liabilities | 713K | 1.8M | 4.4M | (4.4M) | (3.9M) | (3.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Synairgen Stock
The Cash Flow Statement is a financial statement that shows how changes in Synairgen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Synairgen's non-liquid assets can be easily converted into cash.